OPEN END-TURBO-OPTIONSSCHEIN - AMGEN | Market Closed - Boerse Frankfurt Warrants 11:51:17 29/05/2024 am IST | ||
| 0.83 EUR | 0.00% |
|
| Current month | -23.85% | ||
| 1 month | -25.89% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 29/24/29 | 0.83 | 0.00% |
| 28/24/28 | 0.83 | +12.16% |
| 27/24/27 | 0.74 | -3.90% |
| 24/24/24 | 0.77 | +1.32% |
| 23/24/23 | 0.76 | +5.56% |
Real-time Boerse Frankfurt Warrants
Last update May 29, 2024 at 11:51 am IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | HS41XD |
| ISIN | DE000HS41XD2 |
| Date issued | 04/01/2024 |
| Strike | 388.9 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.21 € |
|---|---|
| Lowest since issue | 0.6 € |
| Spread | 0.01 € |
| Spread % | 1.20% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.2
USD
Average target price
316.3
USD
Spread / Average Target
+5.36%
- Stock Market
- Certificates
- Certificat
